HomeStructural heart diseaseValvular Aortic Valve

Valvular Aortic Valve

View Category
Structural heart disease

Lotus Returns with New Strength and the FDA Approval to Compete with Sapien3 and CoreValve Evolut R

After reports of some serious adverse events with first-generation Lotus, the device was pulled off the market—but...
solaci -
Learn More
Structural heart disease

TAVR Learning Curve and Volume-Outcomes Relationship Plateau

Every operator keeps track of their cases. Have they reached their potential or are they still learning...
solaci -
Learn More
Mitral valve

Is Tricuspid Regurgitation after TAVR Significant?

Courtesy of Dr. Carlos Fava. Severe or moderate mitral regurgitation is associated to worse evolution after TAVR. However,...
solaci -
Learn More
Structural heart disease

Kidney Insufficiency and the Risk of Developing Aortic Stenosis in the Future

Chronic kidney disease, even in moderate or severe stages before dialysis, is associated with an increased risk...
solaci -
Learn More
Structural heart disease

Modern Valves Reduce the Need for a Pacemaker

Courtesy of Dr. Carlos Fava. Transcatheter aortic valve replacement (TAVR) has already demonstrated benefit for different risk groups, but...
solaci -
Learn More
Structural heart disease

Subclavian and Axillary Access for TAVR: a Valid Alternative

Courtesy of Dr. Carlos Fava. The femoral approach is preferred when it comes to TAVR, but sometimes it...
solaci -
Learn More
Mitral valve

Mitral Valve Repair with MirtaClip Was Feasible and Safe

Transcatheter mitral valve repair (TMVR) with MitraClip was shown feasible and safe, and therefore a viable option...
solaci -
Learn More
Structural heart disease

We Must Still Fear the “Big Five Complications” After TAVR

Surgical risk scores cannot be used for transcatheter aortic valve replacement (TAVR) and they usually overestimate procedural...
solaci -
Learn More